News

Abbott Defeats Whistleblower Suit Over Diabetic Supplies Bills
A whistleblower’s False Claims Act suit filed in 2021 alleging fraudulent diabetic supplies billing by Arriva Medical LLC, ...
Zacks Investment Research on MSN23h
BBNX Stock May Gain From Abbott Deal to Advance iLet Integration
Beta Bionics, Inc. BBNX recently entered into a strategic agreement with Abbott Laboratories ABT to integrate its iLet Bionic ...
Zacks Investment Research on MSN1h
Should You Continue to Retain Abbott Stock in Your Portfolio Now?
Abbott ABT is witnessing increased global demand for routine diagnostic tests over the past few quarters. The Diabetes Care business continued to benefit from the growing sales of its flagship, sensor ...
The Zacks Analyst Blog Highlights Meta, Palantir, Abbott Laboratories, SandRidge and CompX
META, PLTR and ABT lead this week's Zacks blog as AI growth, strong pipelines and solid earnings drive investor interest.
Abbott Laboratories stock outperforms competitors despite losses on the day
Shares of Abbott Laboratories ABT slipped 1.29% to $132.28 Tuesday, on what proved to be an all-around dismal trading session ...